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Abstract
Background: RNF139/TRC8 is a potential tumor suppressor gene with similarity to PTCH, a tumor suppressor
implicated in basal cell carcinomas and glioblastomas. TRC8  has the potential to act in a novel regulatory
relationship linking the cholesterol/lipid biosynthetic pathway with cellular growth control and has been identified
in families with hereditary renal (RCC) and thyroid cancers. Haploinsufficiency of TRC8 may facilitate development
of clear cell-RCC in association with VHL mutations, and may increase risk for other tumor types. We report a
paternally inherited balanced translocation t(8;22) in a proposita with dysgerminoma.
Methods: The translocation was characterized by FISH and the breakpoints cloned, sequenced, and compared.
DNA isolated from normal and tumor cells was checked for abnormalities by array-CGH. Expression of genes
TRC8 and TSN was tested both on dysgerminoma and in the proposita and her father.
Results: The breakpoints of the translocation are located within the LCR-B low copy repeat on chromosome
22q11.21, containing the palindromic AT-rich repeat (PATRR) involved in recurrent and non-recurrent
translocations, and in an AT-rich sequence inside intron 1 of the TRC8 tumor-suppressor gene at 8q24.13. TRC8
was strongly underexpressed in the dysgerminoma. Translin is underexpressed in the dysgerminoma compared
to normal ovary.
TRC8 is a target of Translin (TSN), a posttranscriptional regulator of genes transcribed by the transcription factor
CREM-tau in postmeiotic male germ cells.
Conclusion: A role for TRC8 in dysgerminoma may relate to its interaction with Translin. We propose a model
in which one copy of TRC8 is disrupted by a palindrome-mediated translocation followed by complete loss of
expression through suppression, possibly mediated by miRNA.
Published: 30 July 2009
Molecular Cancer 2009, 8:52 doi:10.1186/1476-4598-8-52
Received: 8 June 2009
Accepted: 30 July 2009
This article is available from: http://www.molecular-cancer.com/content/8/1/52
© 2009 Gimelli et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
Page 2 of 13
(page number not for citation purposes)
Background
Dysgerminomas are rare ovarian tumors most common in
adolescent women, representing 5–10% of all malignant
ovarian tumors in the first two decades of life. They arise
from germ cells within the gonad and represent the ovar-
ian counterpart of testicular seminoma[1]. Histologically
and clinically dysgerminomas are classified as type II
Germ Cell Tumors (GCT).
The female germ cells enter meiosis during intrauterine
development (11–12 weeks of gestation), whereas for the
male germ cells this only happens after the onset of
puberty. This could explain the difference in incidence of
the type II gonadal GCTs between females and males and
the median age of clinical manifestation. In fact, the
number of target cells (PGCs/gonocytes) for initiation is
significantly lower in females compared with males [2].
RNF139/TRC8  (NM_007218; henceforth, TRC8) is a
potential tumor suppressor gene (TSG) with similarity to
PTCH [3]. Mutations in PTCH result in predisposition to
basal cell carcinoma and medulloblastoma, while its inac-
tivation leads to cell proliferation [4-6]. TRC8 was identi-
fied in a family with the constitutional translocation
t(3;8)(p14.2;q24.1), and hereditary renal cell carcinoma
(RCC) and thyroid cancer[3,7,8]. Recently, a second,
independent, family with hereditary kidney cancer was
discovered that carries a cytogenetically indistinguishable
translocation and a VHL mutation. [9]. Secondary loss of
the wild type TRC8  allele was observed in a subset of
tumor cells, consistent with tumor suppressor function.
TRC8 is a membrane-bound E3 ubiquitin ligase that
inhibits the growth of cells in a ubiquitylation-dependent
manner [10]. Interestingly, its level and stability are mod-
ulated by cholesterol and it interacts with components of
the lipid homeostatic machinery, especially INSIG and
the lipid-regulated transcription factors, SREBP1/2 [11]. A
frequent genetic alteration in both hereditary and spo-
radic RCC is mutation of VHL, which encodes the target-
ing subunit of another ubiquitin ligase complex
responsible for degrading hypoxia inducible factors,
HIF1/2 alpha. TRC8 interacts with VHL and, in fruit flies,
knockdown of either gene led to a similar embryonic phe-
notype [12]. Thus alterations in TRC8 have the potential
to affect cellular growth control and possibly its linkage to
lipid homeostasis and/or hypoxia responses.
TRC8 has been identified as a target of the Translin (TSN)
gene in postmeiotic male germ cells, and testis is known
to contain higher levels of TRC8 mRNA than other tis-
sues[3]. TSN, formerly known as testis brain-RNA binding
protein, is found in the cytoplasm and functions as a post-
transcriptional regulator of a group of genes transcribed
by the transcription factor CREM-tau. Cho et al.[13] iden-
tified four new TSN target mRNAs encoding diazepam-
binding inhibitor-like 5, arylsulfatase A, a tetratricopep-
tide repeat structure-containing protein, and TRC8. These
observations suggest an important function for TRC8 in
germ cells. Here, we describe a paternally inherited bal-
anced translocation t(8;22) in a proposita with dysgermi-
noma. The breakpoints of the translocation are located
within the LCR-B low copy repeat on chromosome
22q11.21, containing the palindromic AT-rich repeat
(PATRR) involved in recurrent and non-recurrent translo-
cations and in an AT-rich sequence inside intron 1 of the
TRC8 tumor-suppressor gene at 8q24.13. This transloca-
tion raises the possibility that disruption of TRC8 may
contribute to development of the proposita's dysgermi-
noma.
Methods
Clinical report
The proband is the only one child born to healthy non-
consanguineous parents with an unremarkable family his-
tory. Neither cancers nor miscarriages were reported
among her relatives. She was born at term after an une-
ventful pregnancy. At birth, her growth parameters were
normal. The neonatal period was normal. She was
referred to our Institute at the age of 11 years because of
persistent abdominal pain with fever and evidence of a
pelvic solid mass discovered with ultrasonography in
another hospital.
A total body CT scan upon admission showed a large (17
× 12 × 10 cm) inhomogeneous and necrotic mass arising
from the pelvis with important displacement of the uri-
nary tracts and bilateral hydronephrosis; a concomitant
peritoneal fluid was also present in the pouch of Douglas.
No distant lesions were detected in other abdominal
organs, CNS and lungs. The Tc-99 scintigraphy was nega-
tive for bone lesions. Among serum markers, only LDH
(12980 U/L) (N.V. 84–362 U/L) and β-hCG (113 U/L)
(N.V. <5 U/L) were abnormal for age, suggesting the
hypothesis of a germinal tumor. A surgical approach was
decided as first treatment. During surgery, a tumoral mass
arising from the left ovary was completely resected with
consensual monolateral annessectomy; a biopsy of the
contra lateral ovary and a sample of peritoneal fluid were
also sampled for histological evaluation.
Histological analysis confirmed a classic dysgerminoma
of the ovary without evidence of tumoral cells in other tis-
sue samples. No chemotherapy was administered after
surgery according to Italian protocol (TCG 2004) for stage
1 ovarian dysgerminoma and the patient was discharged
with a follow-up program. Nine months after the diagno-
sis the patient is healthy and shows normal β-hCG values
for age.Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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Hystology and Immunohistochemistry
Formalin-fixed paraffin-embedded tissue specimens were
cut from paraffin blocks and stained with hematoxylin
and eosin for microscopic examination. Immunohisto-
chemical labelling was performed by a three-step indirect
immunoperoxidase technique. Formalin fixed, paraffin
embedded, 3 micron serial tissue sections were incubated
at room temperature for 30 minutes with the antibodies
reported in Table 1. Additional sections were incubated
overnight at 4°C with a rabbit polyclonal antibody
against the C-terminus of the p145 human c-kit protein
(Oncogene, Boston, MA, USA) and with hypoxia-related
Table 1: Antibodies
Antibody Source
anti-MNF116 cytokeratin mAb) (clone MNF116, Dako; Glostrup, Denmark
anti-AE1/AE3 cytokeratin mAb (clone AE1/AE3, Dako)
anti-CD66e mAb (clone 12-140-10, Novocastra; Newcastle, UK)
anti-EMA mAb (clone GP1.4, Novocastra)
anti-vimentin mAb (clone V9, Novocastra)
anti-PLAP mAb (clone 8A9, Novocastra)
anti-beta HCG mAB (Novocastra)
anti-NSE mAb (clone 5E2, Novocastra)
anti-GFAP mAb (clone GA5, Novocastra)
anti-desmin mAb (clone DE-R-11, Novocastra)
anti-Ki 67 mAb (clone MIB-1, Dako)
anti-CD31 mAb (clone JC70A, Dako)
anti-CD45 (clone T29/33, Dako)
anti-CD68 mAb (clone KP1, Dako)
anti-CD117 polyclonal Ab (Dako)
p145 human c-kit protein (Oncogene, Boston, MA, USA)
CD30 (Clone BER-H2)Dako
S100 Polyclonal Ab, Dako
CD3 Polyclonal Ab, Dako
CD20 Clone L26, Dako
CD45 Clone T29/33, Dako
CD56 Clone CD564, Novocastra
Synaptophysin Clone SY38, Dako
Chromogranin A Clone DAK-A3, DakoMolecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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antibodies: anti-HIF-2α mAb (clone ep190p, Abcam;
Cambridge, UK), anti-VEGF polyclonal Ab (Santa Cruz
Biotechnology; Santa Cruz, CA), anti-FGFR (clone VBS1,
Chemicon; Temecula, CA), anti-VHL (clone 3F391,
Abcam), anti-CA IX polyclonal Ab (Abcam), anti-COX2
polyclonal Ab (Abcam), anti-IGF1R (clone SPM138,
Abcam). A monoclonal antibody anti-RNF139/TRC8
(Abcam) was used on normal fallopian tube and dysger-
minoma specimens from our proposita.
Sections were subsequently incubated at room tempera-
ture with anti-mouse or anti-rabbit Ig antibodies conju-
gated to peroxidase-labelled dextran polymer (Dako). The
chromogen 3, 3-diaminobenzidine was used in the pres-
ence of hydrogen peroxide. Slides were counterstained
with Mayer's haematoxylin.
Negative controls were performed using blocking serum
in place of primary antibody. Positive and negative con-
trols were run in parallel with each batch, and appropriate
results were obtained. Finally, histochemical reaction of
cryosectioned tumor was used to evaluate lipid deposi-
tion. Cryosections were fixed in 10% neutral buffered for-
malin. Samples were stained with Oil Red "O" kit
(Diapath, Martinengo, Italy).
Cytogenetics investigations
Chromosome preparations were made from cultured lym-
phocytes from the proposita and her parents using stand-
ard high-resolution techniques. To define the breakpoint
of the translocation we used fluorescent in situ hybridiza-
tion (FISH) with BAC clones spanning the chromosomal
8q24.1 and 22q11.2 regions selected according to the
University of California Santa Cruz (UCSC) Human
Genome Assembly (March 2006 assembly).
FISH analysis on paraffin embedded tumoral tissue
To prepare paraffin-embedded tissue sections fixed on
positively charged slides, we cut 4 – 5 μm thick paraffin
sections using a microtome. Floating sections were
mounted on positively charged slides. To deparaffinize
specimens, slides were treated by Paraffin Pretreatment
Kit (Abbott Molecular Inc., IL, USA) and treated with pro-
tease, then hybridization was performed with the appro-
priate Vysis protocol.
Array – CGH analysis
Molecular karyotyping was performed using the Human
Genome CGH Microarray Kits 44B and 244A (Agilent
Technologies, Palo Alto, CA, USA) covering the whole
genome with a resolution of ~100 kb and ~35 Kb, respec-
tively. Briefly, 1 μg of patient and sex-matched pooled ref-
erence DNAs were processed according to the
manufacturer's protocol. Fluorescence was scanned in a
dual-laser scanner and the images were extracted and ana-
lyzed with Agilent Feature Extraction software (v9.5.3.1)
and CGH Analytics software (v3.5.14) respectively.
Changes in test DNA copy number at a specific locus are
observed as the deviation of the log ratio value from a
modal value of 0.
Generation of somatic cell hybrids
Somatic cell hybrid clones were generated by fusing the
HPRT-negative RJK88 Chinese hamster cell line with lym-
phoblastoid cell lines (LCLs) from the patient[14].
DNA extraction and genotyping
Genomic DNA from fresh and frozen samples was
extracted using a standard proteinase K digestion, fol-
lowed by phenol/chloroform extraction, and resuspended
in water. FFPE material from rolled sections was extracted
using the QiaAmp DNA Mini Kit (Qiagen) according to
manufacturer's instructions, with minor modifications.
DNA quantitation was determined by spectrophotometry
(NanoDrop, Thermo Scientific, Wilmington, DE). Other
genomic DNAs from tissues and cell lines were extracted
with DNAzol (MRC, Inc, Cincinnati, OH). Genotyping of
polymorphic loci was performed by amplification with
primers labeled with fluorescent probes (ABI 5-Fam, Hex
and Tet) followed by analysis on an ABI 310 Genetic Ana-
lyzer (Applied Biosystems). Non-polymorphic loci were
assayed by electrophoresis on agarose gels. All primers
were purchased from MWG Biotech AG (Ebersberg, Ger-
many). The sequences of all primers used are available
from the authors.
Southern blot analysis was conducted on 5 μg aliquots of
genomic DNA cut with SacI and PstI restriction enzymes.
The DNAs were separated on 0.8% agarose/0.5× TBE gels,
transferred to Hybond-N+ (GE Healthcare, Italy), hybrid-
ized to non-radioactively labelled probes (Gene Images
Random-Prime DNA Labeling kit, GE Healthcare, Italy)
and detected with CDP-Star detection reagent (GE Health-
care, Italy).
Expression analysis
Total RNA was extracted from all tissues and cell lines
with Trizol (Invitrogen, Milano, Italy) following manufac-
turer's protocols. Additional Human Tissue Total RNA
was purchased from Stratagene. cDNA synthesis was per-
formed with Ready-To-Go You-Prime First strand beads
(Amersham) and random hexamers; Non-quantitative
RT-PCR was performed in 25 μl reactions, using JumpStart
Red ACCUTaq LA DNA polymerase (Sigma) and the fol-
lowing protocol: 1 min at 96°C; 30 cycles of 30 sec at
94°C/30 sec at 58°C/2 min at 68°C; 5 min at 68°C final
elongation time; PCR products were analysed on 1.5%
agarose TAE gels. G3PDH amplification primers and pro-
tocol were from Clontech.Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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Quantitative gene expression was assessed by Real-Time
Quantitative PCR (RT-Q-PCR) on a 7900 HT Sequence
Detection System (Applied Biosystems) using
SYBR®Green PCR Master Mix (Applied Biosystems). Vali-
dation experiments demonstrated that amplification effi-
ciencies of the control and all target amplicons were
approximately equal (not shown); accordingly, relative
quantification of DNA amount was obtained using the
Comparative CT method (described in Applied Biosys-
tems User Bulletin #2, December 11, 1997: ABI PRISM
7700 Sequence Detection System).
TRC8 mutation and CpG island methylation analysis
Primer pairs were selected covering the promoter region
(1 pair), exon 1 (1 pair), and the protein coding region of
exon 2 (4 pairs) of the TRC8 gene. PCRs were performed
in 25 μl reactions, using JumpStart Red ACCUTaq LA
DNA polymerase (Sigma) and the following protocol: 30
sec at 96°C; 35 cycles of 30 sec at 94°C/30 sec at 60°C/2
min at 68°C; 10 min at 68°C final elongation time; 5%
DMSO was added to promoter and exon 1 PCRs. All PCR
products were analysed on 1.5% agarose TAE gels.
We also analyzed CpG methylation of the TRC8 pro-
moter-associated CpG island. Bisulphite treatment was
carried out as described by Kubota et al.[15]. Methylation
levels were tested by sequencing and restriction mapping
of the fragments amplified from bisulphite-treated DNA
with TaqI restriction enzyme. The VHL gene was
sequenced from tumor and normal DNA according to the
methods described by Poland et al. [9].
Results
Histology and Immunohystochemistry
The left ovary measured 17 × 12 × 10 cm and its weight
was 1,115 g. The cut surface was solid, partly nodular, and
fleshy, with gray/rose coloration and some necrotic areas.
Histologically, the tumor was composed of uniform cells
consistent with a diagnosis of dysgerminoma. No metas-
tases were demonstrated microscopically in any of the ret-
roperitoneal lymph nodes examined. The right ovary was
apparently normal with a light elongated shape.
The tumor showed strong positive staining (with mem-
brane enhancement) for PLAP, CD117 and CD68, focal
positivity for MNF116, while the balance of antibodies
were negative. TRC8 was positive in normal Fallopian
tube but negative in the dysgerminoma (Fig. 1A, B).
Expression profiles of hypoxia-related tissue factors were
as follows: HIF-2α and FGFR expression was detectable
only in a minority of cells, while VHL and CA IX were con-
sistently expressed in the context of CD117 positive vital
tumor tissue (Fig. 1C–G); in the same areas, immunolabe-
ling with the C-terminus of the p145 human c-kit protein
was negative. Histochemical reaction with Oil Red "O" on
cryosectioned tissue tumor showed a moderate deposi-
tion of lipids in selected areas (Fig 1H).
Cytogenetic analysis and mapping of the translocation 
breakpoints
Giemsa staining identified a chromosomal translocation
(8;22)(q24.13;q11.21) in the proband (Fig. 2A, B). The
translocation was also present in her apparently normal
father, while her mother had a normal karyotype. No
additional relative in the paternal lineage was available
for testing. FISH analysis using genomic clones localized
Immunohistochemical analysis of antigens in dysgerminoma Figure 1
Immunohistochemical analysis of antigens in dysger-
minoma. (A) normal Fallopian tube; (B-H) dysgerminoma. 
(A) intense TRC8 immunoperoxidase expression in control 
tissue. (B) negative immunoperoxidase TRC8 reaction in dys-
germinoma; C, CD117 strong membrane staining in dysger-
minoma; D, diffuse and intense VHL expression; E, FGFR 
cytoplasmic expression; F, diffuse and intense CAIX expres-
sion; G, HIF2alpha nuclear and cytoplasmic expression in 
sporadic cells; H, moderate lipid deposition detected by Oil 
Red O. Original magnification A-H ×100.Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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the translocation breakpoints to within RP11-562F10
(GenBank Accession No. AZ537723) at 22q11.21 (Fig.
2C) and RP11-158K1 (GenBank Accession No.
AF313041) at 8q24.13 (Fig. 2D). Five known genes have
been mapped to the RP11-158K1 clone (TRMT12, TRC8,
TATDN1, NDUFB9, MTSS1) and three to RP11-562F10
(ZNF74, SCARF2, KLHL22). This latter BAC clone also
contains two segmental duplications, DC3315 and
DC3316.
To further characterize the breakpoints, we generated
somatic cell hybrids from the lymphoblastoid cell line of
the proposita. From 100 hybrid clones, one contained
only a normal chromosome 8, six retained a normal chro-
mosome 22, seven retained the der(8) and four retained
the der(22) chromosome. Based on the UCSC (March
2006 freeze) map, we typed the hybrids for informative
chromosome 8 markers (see Table 2) and localized the
breakpoint to a 700 bp region in intron 1 of the TCR8
gene. This region contains an AluSp and a 180 bp (AT)n
simple repeat (Fig. 3A, B).
The 8q24 breakpoint region was refractory to amplifica-
tion (not shown). We examined the repeat-rich segment
by digestion with SacI followed by Southern blot analysis
and observed two bands both in the proband and her
father; the larger shared fragment presumably contains
the rearrangement's breakpoint. One of the normal con-
trol samples also contained two alleles; in all cases, the
fragments were several hundred bases larger than in the
RP11-158K1 clone (Fig. 3B), consistent with polymor-
phism of the AT-rich VNTR.
On chromosome 22, the breakpoint was localized to the
LCR-B [16]/LCR22-3a [17] which is the same region
involved in the recurrent t(11;22)(q23;q11.2) [16,18,19]
as well as t(17;22)(q11.2;q11.2) and several other trans-
locations [17] (Fig. 3C). Since most of the 22q11 break-
points involved in these translocations occur at the center
of PATRR22, we postulated that this was also the most
likely breakpoint in our case, but the breakpoint junctions
could not be amplified using the method described by
Gotter et al[20].
To investigate the presence of the translocated chromo-
somes in the tumoral tissue, we performed a dual colour
hybridization experiment on deparaffinized slices from
the dysgerminoma (summarized in Fig. 4). We used a
probe specific for the centromere of chromosome 8
(CEP8; Vysis) to visualize its copy number in single cells.
To detect the normal and derivative chromosomes 8 and
22 we used dual FISH with BACs RP11-383J24 (chromo-
some 8) and CTD-2319K10 (chromosome 22) both adja-
cent to the breakpoints, to unambiguously identify the
derivative 8 (Fig. 4C). Dual FISH was also performed with
BACs CTD-3107D22 (chromosome 22) and RP11-
532M24 (chromosome 8) to detect the derivative 22 (Fig.
4D). This experiment revealed that ~40% of tumor cells
contained two copies of the derivative 8 while while the
remaining 60% contained one copy. Similar results were
obtained for the derivative 22; all cells also contained one
normal chromosome 8 and one normal chromosome 22.
Array-CGH results
We carried out array-CGH analysis on the dysgermi-
noma's DNA to map all chromosomal imbalances at ~100
kb average resolution. Non-mosaic gain of an entire chro-
mosome was detected for chromosomes 7 and 15, while
mosaicism for a whole-chromosome gain was detected for
chromosomes 1, 6, 16, 19, 20, and 21 (not shown). A
structural chromosomal imbalance was detected for chro-
mosomes 2, 4, 8, 11, 12, 17, and 22, both as gain or loss
(see Table 3). Array comparative hybridization profiles of
the abnormal chromosomes are shown in Fig. 5. Array-
CGH analysis with 8.9 KB overall median probe spacing,
performed on the genomic DNA of our proband and her
parents, excluded a concomitant deletion or duplication.
VHL gene mutations
The proband was heterozygous for multiple VHL SNPs in
her blood DNA, while her father was homozygous for all
Cytogenetics and FISH results from the proposita's lym- phocytes, A, cut-out and B, idiogram of the normal (left) and  derivative (right) chromosomes 8 and 22 Figure 2
Cytogenetics and FISH results from the proposita's 
lymphocytes, A, cut-out and B, idiogram of the nor-
mal (left) and derivative (right) chromosomes 8 and 
22. C, FISH with BAC RP11-562F10 (red signals) spanning 
the breakpoint on the long arm of chromosome 22. D, FISH 
with BAC RP11-158K1 demonstrates that the chromosome 
8 breakpoint is within this clone. Arrowheads indicate the 
signal on the normal chromosome while arrows mark deriva-
tive chromosomes.Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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Map of the translocated regions Figure 3
Map of the translocated regions. (A) schematic of the genomic region rearranged on chromosome 8 showing the translo-
cation breakpoint (black arrowhead), the BAC clones used to refine the cytogenetic characterization (colored bars), and the 
molecular localization of the breakpoint to an AT-rich simple repeat (light grey box) in intron 1 of the TRC8 gene. The position 
of the SacI restriction sites (S) and of the probe used for Southern analysis are indicated. (B), Southern blot showing SacI-
cleaved fragments of the first intron containing the AT-rich repeat in the proband (P), her father (F), several normal controls 
(C1–3) and the BAC RP11-158K1 (Bac). Positions of the proband's alleles (arrows) and two molecular weight markers are 
shown. (C) Localization of the chromosome 22 breakpoint, contained within BAC RP11-562F10.Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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Table 2: Genomic typing of somatic cell hybrid clones with chromosome 8 and 22 markers.
Locus Position (Kb) Genomic Chr. 8 Chr. 22 der(8) der(22)
Chromosome 8 D8S1784 106172 287 287 287
D8S514 123811 221/223 223 221
D8S1832 125517 180/186 180 186
RH1927 125534 + + +
RNF139 E1 125556 + + +
Chr8-2-1 125559 + + +
Chr8-2-2 125562 + + +
Chr8-3-1 125563 + + +
Chr8-3-2 125564 + + +
Chr8-2-3 125565 + + +
RNF139 E2 125567 + + +
TATDN1 E10 125570 + + +
TATDN1 E6 125590 + + +
NDUFB9 E2 125625 + + +
NDUFB9 E4 125631 + + +
MTSS1 E14 125635 + + +
MTSS1 E13 125637 + + +
MTSS1 E11 125639 + + +
D8S1799 125646 234 234 234
D8S272 137804 241/255 255 241
Chromosome 22 D22S427 16971 100 100 100
RH78249 18480 + + +
RH57884 18609 + + +
RH102235 19092 + + +
RH93744 19126 + + +
D22S280 31539 210/212 210 212Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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of them. We amplified by long-range PCR and sequenced
all exons of the VHL gene on 3p25.3 in both directions
from tumor DNA, finding no evidence of mutations or
loss of heterozygosity.
Expression analysis
Non-quantitative RT-PCR analysis of TRC8 showed that
the gene was expressed in the Epstein-Barr Virus (EBV)
line and in the hybrid clone containing a normal chromo-
some 8, but not in hybrids carrying the der(8) or der(22)
chromosomes (Fig. 6). In contrast, the neighbouring
genes  TATDN1  and  NDUFB1  were expressed in the
der(22) hybrid. Expression of all three genes was detecta-
ble in the dysgerminoma.
Using Real-Time RT-PCR, we quantitated expression of
TRC8 in normal human ovary and testis, in the dysgermi-
noma, in EBV lines from the proband and her father, and
in three additional EBV lines from normal subjects. Ovary
and testis RNA come from pooled samples (ovary: 15 cau-
casian females, aged 20–60; testis: 39 caucasian males,
aged 14–64) and consequently can be considered "aver-
aged" tissue samples. We also analyzed the expression of
HMGCR and SCD1, two SREBP target genes potentially
down-regulated by TRC8 in RCC cells, and of the house-
keeping gene PGK (Fig. 7A). Compared to normal ovary,
TRC8 was expressed approximately 10 times less in the
dysgerminoma. In contrast, it was expressed 4-fold more
in testis. All lymphoblastoid lines expressed TRC8 at very
low levels, and there was no difference in expression
between the subjects carrying the translocation and the
control lines. Because of low TRC8  expression in the
tumor, we anticipated that SREBP target genes, including
HMGCR and SCD1 might be overexpressed. In contrast,
we observed that SCD1  was strongly underexpressed
while  HMGCR  was not affected in the dysgerminoma
compared to normal ovary. Perhaps the complex regula-
tion of each gene makes it difficult to discern the effect of
reduced TRC8, or the whole ovary is not a good control
tissue for germ cell expression. In addition, regulation of
lipid homeostatic genes by TRC8 may be specific for some
tissues or tumors. The level of PGK expression was compa-
rable in all tissues.
We quantified expression of the TSN gene encoding trans-
lin, a protein involved in post-transcriptional regulation
of a number of genes, including TRC8, during sperma-
togenesis (Fig. 7B). TSN was expressed approximately 3
times more in the testis than in normal ovary, while it was
expressed approximately two times less in the dysgermi-
noma. Expression was homogeneously lower in all EBV
lines. Due to the rarity of dysgerminomas, our findings are
limited to the one sample we were able to collect and ana-
lyze; whether or not these expression levels are character-
istic of dysgerminomas or unique to this translocation
case is unknown.
Analysis of tumor-derived TRC8 for genetic and epigenetic 
changes
Genomic DNA sequences, including the TRC8 promoter
and exons 1 and 2, were examined from both the
proband's EBV line and the dysgerminoma. There were no
differences between the two sequences, and both were
identical to the human reference sequence (NC_000008,
from 125556189 to 125570040). Sequences of the TRC8
transcript reverse-transcribed from the EBV line and dys-
germinoma were also identical to the database. Lastly, we
examined promoter methylation patterns of TRC8, and
found it was completely unmethylated in both tissues
(not shown)
Discussion
We report a girl who developed a dysgerminoma at the
age of 10 years and carries a balanced translocation
t(8;22)(q24.13;q11.21). The breakpoints of our proposita
Interphase FISH on deparaffinized sections from dysgermi- noma Figure 4
Interphase FISH on deparaffinized sections from dys-
germinoma. a) schematic representation of the results of 
the interphase FISH. b) Nuclei show two or three red signals 
(CEP8) indicating the presence of nuclei with two or three 
chromosomes 8, respectively.c) Dual color hybridization 
with BAC RP11-383J24 (red signal) and BAC CTD-2319K10 
(green signal) indicate the presence of a normal chromosome 
8 and a normal chromosome 22 (single signals); nuclei show 
one or two derivative chromosome 8 (arrows). d) Dual 
color hybridization with BAC CTD-3107D22 (red signal) and 
BAC RP11-532M24 (green signal) indicate the presence of a 
normal chromosome 8 and a normal chromosome 22 (single 
signals) and one or two derivative chromosome 22 (arrows).Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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may be identical to those recently described by Gotter et
al., [20]. In that case, the proband showed an unbalanced
translocation with a supernumerary der(22) derived as a
result of 3:1 meiotic malsegregation of the paternal bal-
anced translocation 46, XY, t(8;22)(q24.13;q11.21). The
proband showed an abnormal phenotype, while his
father was apparently normal. Interestingly, a breakpoint
within the first intron of the TRC8  gene has been
described as an inherited rearrangement associated with
renal cell carcinoma in two unrelated families[3,9,21,22].
In our case, we have localized the breakpoint to a 700 bp
region in intron 1 of the TCR8 gene, containing an AluSp
and a 180 bp (AT)n simple repeat. The breakpoint is prob-
ably positioned, as in the family described by Gotter et
al.[20], in a palindrome within the simple repeat. In our
case and in Gotter et al.[20], the breakpoint on chromo-
some 22 lies within the PATRR on 22q11. The analysis of
many unrelated t(11;22)(q23;q11) cases revealed that the
breakpoints occur within palindromic PATRRs on 11q23
and 22q11 (PATRR11 and PATRR22). The majority of the
breakpoints, including the case described by Gotter et
al.[20], are localized to the centre of the PATRRs, suggest-
ing that the palindrome mid-point is susceptible to dou-
ble-strand breaks (DSBs); this would occur as the result of
a cruciform extrusion promoting the DSBs that initiate
stabilizing rearrangements or recombination events[23].
The PATRR22 appears to be highly unstable in the human
genome[24]. Palindrome-mediated genomic instability
contributes to a variety of genome rearrangements includ-
ing not only constitutional translocations, but also large
germ line deletions[25]. Cancer-related gross chromo-
somal rearrangements and genomic amplification are also
reported to be associated with palindromic DNA[26,27].
Recent studies have produced a detailed map showing
that palindromes tend to cluster at specific regions, some
of which undergo gene amplification[28]. Individual
tumors seem to have a non-random distribution of palin-
dromes in their genomes, and a subset of palindromic loci
is associated with gene amplification. Inverted repeats or
palindromes are known to generate hairpins or cruciform
structures, facilitated by intrastrand pairing of comple-
mentary single-strand DNA sequences assembled in the
lagging strand during DNA replication. A double-strand
break (DSB) introduced in these hairpins can result in
deletions or in either inter- or intrachromosomal recom-
bination events mediated by the homologous recombina-
tion machinery[26,28].
TRC8  encodes an endoplasmic reticulum-resident E3-
ubiquitin ligase with multiple transmembrane segments.
TRC8 contains a C-terminal RING-H2 domain shown to
catalyze in vitro ubiquitylation reactions[10,11]. In Dro-
sophila and mammalian cells, over-expressed TRC8 sup-
pressed growth[11,12,29]. In HEK293 cells, TRC8
induced G2/M arrest and accumulation of sub-G1 cells
indicative of apoptosis[11]. These effects were dependent
upon an ubiquitylation-competent RING domain, sug-
gesting that specific substrates were critical to growth inhi-
bition. Tumor formation in a nude mouse model was also
inhibited by TRC8 in a RING-dependent manner. TRC8
contains a putative sterol-sensing domain (SSD) which in
other proteins confers sensitivity to sterols, affecting either
stability or trafficking between membrane compart-
ments[3]. Moreover, knock-down of endogenous TRC8
increased levels of the lipid homeostasis transcription fac-
tors, the SREBPs and their target genes, including enzymes
of cholesterol and lipid metabolism [11]. However, these
effects were only evident in cells simultaneously depleted
of sterols, since cholesterol-replete cells contain very low
amounts of TRC8. Importantly, expression of activated
SREBP-1 partially restored the growth of TRC8-inhibited
cells [11], indicating that changes in lipid regulation
underlie some of the growth inhibitory actions of this
tumor suppressor. Since these data suggested that TRC8
activity linked growth control to the cholesterol/lipid
homeostasis pathway, we analyzed two SREBP target
genes, HMGCR and SCD1, in control and tumor tissue
(Fig. 6). However, expression levels were depressed com-
Array comparative genome hybridization profiles of the  chromosomes involved in rearrangements in the dysgermi- noma Figure 5
Array comparative genome hybridization profiles of 
the chromosomes involved in rearrangements in the 
dysgerminoma.Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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pared to normal ovarian tissues. This could be due to lack
of proper control tissues (germ cells as opposed to whole
ovary) or perhaps more likely to the presence of plentiful
lipids, since the effects of TRC8  loss are most readily
observed following sterol-depletion [11].
Interestingly, TRC8 expression appeared down-regulated
in tumor tissue (Fig. 6) while TRC8 protein was not
detectable in tumor tissue by IHC (Fig. 1). This was
despite the absence of any evidence for loss, genetic alter-
ation or promoter methylation of the remaining TRC8
allele. We surmise that additional mechanisms reducing
TRC8 expression may be involved in this dysgerminoma.
For example, the 3' UTR of TRC8 contains target sites for
multiple microRNAs (miR), several of which are highly
conserved among human, mouse, rat, dog and chicken
(miR-218, -101, -27, -128, -375). In addition, the coding
sites for some of these miRs are found on the aneuploid
chromosomes observed in this tumor (i.e., miR-218-1 is
on chromosome 4). It is possible that miRNAs are medi-
ating the additional loss of expression for this gene.
Recently, the stabilization of specific miRNAs by Translin
in male germ cells has been reported[30].
In our patient Translin (TSN), a protein involved in post-
transcriptional regulation of TRC8 and of a number of
genes during spermatogenesis, is expressed two times less
in the dysgerminoma than in normal ovary.
Table 3: List of the imbalances found in the analysis of the Dysgerminoma.
Chr Chromosome Band Gain/Loss* Position Size (Mb) Notes
Chr 2 2p24.1 → 2q37.1 enh Chr2:24,134,000..233,241,000 209.10 mosaic 30%
Chr 2 2q37.1 → qtel enh Chr2:233,241,000..242,951,149 9.71 More copies
Chr 4 4q21.21 → qtel dim Chr4:80,599,000..191,273,063 110.70 mosaic 30%
Chr 8 8ptel → q24.13 enh Chr8:1..125,719,000 125.70
Chr 8 8q24.13 → qtel enh Chr8:125,719,000..146,274,826 20.56 mosaic 30%
Chr 11 11p15.3 → 11q23.3 dim Chr11:11,570,000..119,487,000 107.90 mosaic 30%
Chr 11 11q23.3 → qtel dim Chr11:119,487,000..134,452,384 14.97
Chr 12 12ptel → q23.1 enh Chr12:1..94,196,000 94.20 More copies
Chr 12 12q23.1 → qtel enh Chr12:94,196,000..132,349,534 38.15
Chr 17 17q21.3 → qtel enh Chr17:38,922,000..78,774,742 39.85 mosaic 30%
Regions interested by the deletions/duplications/triplications are reported together with their mapping position and cytogenetic bands (hg 17/Build 
35, May 2004), The size of each imbalance is always related to the platform resolution having 100 kb average distribution of the clones along the 
genome. The size of the intervening regions is shown, although it should be considered that breakpoints may fall within a segment of 100 kb 
(average) proximal and distal to the starting and ending clones. * Enh = enhanced log2 ratio (gain); dim = diminished log2 ratio (loss).
Non-quantitative RT-PCR analysis for expression of TRC8,  TATDN1, NDUFB9 in cell lines and dysgerminoma Figure 6
Non-quantitative RT-PCR analysis for expression of 
TRC8, TATDN1, NDUFB9 in cell lines and dysgermi-
noma. RNA isolated from indicated hybrids and proband's 
nomal or tumor tissues was reverse transcribed and used for 
PCR amplification with the indicated gene-specific primers. 
The housekeeping gene PGK was used as a control; MWM, 
molecular weight marker V (Roche); Neg, no DNA control.Molecular Cancer 2009, 8:52 http://www.molecular-cancer.com/content/8/1/52
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Translin, formerly known as testis brain-RNA binding
protein (TB-RBP), is both a DNA-binding and RNA-bind-
ing protein. As a DNA binding protein, it interacts with
the breakpoint junctions of chromosomal transloca-
tions[31,32]. Translin also mediates intracellular and
intercellular mRNA transport, possibly controlling the
temporal and spatial translation of specific mRNAs in
postmeiotic germ cells [33-35]. Kasai et al. [36] have pro-
posed that human Translin may play a role in DNA
recombination, repair, and metabolism, but deficiencies
in somatic recombination or DNA repair are not readily
detectable in mice lacking Tsn [37]. However, the marked
increase in apoptosis of spermatocytes in Tsn-null mice
suggests a role for TSN during meiosis, perhaps function-
ing as a post-transcriptional regulator in spermatocytes
[37]. Recently, Cho et al. [13] identified four meiotic
mRNA targets of Translin, one of which is TRC8. They
hypothesized that disruption of the precise regulation of
TRC8 may cause the growth retardation and the increased
apoptosis in pachytene spermatocytes observed in Tsn-
null mice [37]. To our knowledge, there are no studies of
the role of the TSN gene in female meiosis.
TRC8 is a potent TSG involved in different tissue-specific
pathways. Its haploinsufficiency may facilitate the devel-
opment of CC-RCC in association with VHL mutations, or
otherwise lead to increased risk for other types of tumor.
Any role in dysgeminoma may relate to its interaction
with translin. We envision a model whereby one copy of
TRC8 is disrupted by palindrome-mediated translocation
(step 1), then, in a second step, translin, miRNA, or
another yet undiscovered mechanism leads to further loss
of TCR8 expression, setting the stage for deregulated pro-
liferation.
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